Oral anticoagulation discontinuation after atrial fibrillation ablation: a systematic review and meta-analysis of randomized trials
Ahmed Salih, Antonio Creta, Hussam Ali, Riccardo Cappato, Rui Providencia · 2026
Read Oral anticoagulation discontinuation after atrial fibrillation ablation: a systematic review and meta-analysis of randomized trials by Ahmed Salih, Antonio Creta, Hussam Ali, Riccardo Cappato, Rui Providencia (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13252450.txt.
Description
Ahmed Salih and four co-authors pool, in a 2026 review, the trial proof on stopping blood thinners after a heart procedure for atrial fibrillation. The procedure, ablation, burns away the faulty signals and cuts attacks. Whether patients who stay rhythm-free can safely drop their anticoagulant pills, which guard against stroke but raise bleeding risk, was unsettled.
Three trials with 2,324 patients fit the review. All patients had stayed free of the rhythm fault for at least six months. Over about two years, stopping the pills did not raise stroke rates, and no body-wide clots occurred in either group. Keeping the pills did raise major bleeding in a clear way. The authors read the proof as favouring a careful stop for such patients.
Catalog record
| CREATOR | Ahmed Salih, Antonio Creta, Hussam Ali, Riccardo Cappato, Rui Providencia |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 37 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |